Science & Environnement
optional screen reader
Pfizer begins early stage clinical trial testing oral antiviral drug for Covid
-
AstraZeneca says US data shows COVID-19 vaccine prevents 79% of symptomatic disease
It would be the fourth vaccine authorized for use in the U.S., alongside ones from Pfizer-BioNTech, Moderna, and Johnson & Johnson.
-
‘No evidence’: Vaccine claim rubbished
The chief medical officer says there is no need to suspend the AstraZeneca vaccine rollout, after two government-aligned MPs called for a pause.
-
Russia accused of spreading vaccine disinformation to protect Sputnik V
Russian officials have dismissed accusations that they spread disinformation about rival vaccines as “nonsense”.
Latest Science & Environnement
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The J&J vaccine was found in its large trial to be 72% effective in the USA but less effective in South Africa and Latin America, where variants circulated.
Moderna study suggests half doses offer strong immune response, but experts caution against changing approach
'Significant' immune response from both full and half doses, company's team says
COVID-19 in the UK: South African strain spreads
Concerns are mounting in the UK after the South African mutant strain was detected in eight areas, with no cases linked to international travel.
US north-east hit by snowstorm with blizzard-like conditions predicted
New York, New Jersey and Connecticut may see 18in of snow, with storm reaching Massachusetts and northern New England Monday
Coronavirus: Moderna vaccine ‘effective’ against South African strain
A vaccine manufacturer says it believes it can combat a highly-contagious new COVID-19 strain as Jacinda Ardern delivers a virus-related warning.
France’s Pasteur Institute says it is abandoning its principal Covid-19 vaccine project
France's Pasteur Institute said on Monday it was ending development of a Covid-19 vaccine with US pharmaceutical company Merck after clinical trial results proved disappointing.
Covid-19: Pfizer-BioNTech vaccine works against UK, South African variants, study says
German company BioNTech said Friday a preliminary study shows that its vaccine works against a key mutation in coronavirus variants uncovered in Britain and South Africa which experts have said is more contagious than normal coronavirus strains.
The Coronavirus Is Mutating. What Does That Mean for Us?
Officials in Britain and South Africa claim new variants are more easily transmitted. There’s a lot more to the story, scientists say.
Britain becomes the first country to license a fully tested covid-19 vaccine
Inoculations with the Pfizer-BioNTech jab could start in less than a week
Moderna To Ask U.S., European Regulators To Allow Use Of COVID-19 Vaccine
Moderna said it got the final needed results over the weekend that suggest its vaccine is more than 94% effective.
Sydney records hottest November night on record
Sydney has recorded its hottest November night on record, with daytime temperatures of 40C on Sunday.
Moderna: Covid vaccine shows nearly 95% protection
A new vaccine that protects against Covid-19 is nearly 95% effective, early data from US company Moderna shows.
Moderna COVID Vaccine More Effective Than Pfizer: 'Tremendously Exciting'
Awaiting fuller safety data later this month, Moderna said it plans to seek federal authorization for shot by early December
Storm Alex: Floods and landslides hit France and Italy
At least two people have died and up to 20 are still missing after a powerful storm hit south-eastern France and north-western Italy.
US West Coast fires: Is Trump right to blame forest management?
With fires raging across California, Oregon and Washington in the US, President Trump has repeatedly criticised the way forests in these states are
